Patients intending to use semaglutide should have a prescription from a licensed health care provider and only obtain medicines from state-licensed pharmacies or outsourcing facilities registered with FDA, the agency said.
If buying from unregulated and unlicensed sources, patients should know they may be exposed to potentially unsafe products, the FDA cautioned.
Health care providers should also be aware that compounders may be using salt forms of semaglutide, the FDA noted.
Semaglutide mimics the GLP-1 hormone that is released by the gastrointestinal tract in response to eating. It is meant to prompt the body to produce insulin and thus lower blood glucose. It can also reduce appetite.
Three FDA-approved semaglutide products are sold in the marketplace. These include Ozempic and Rybelsus, which are approved for lowering blood sugar levels in those with